• Obtain cultures and begin IV antibiotics promptly. Empirical treatment must cover S. aureus.
• Where MRSA prevalence is low, cefazolin 50 mg/kg IV every 8 hours, maximum 2 g per dose, is appropriate.
• Where MRSA is significant, clindamycin 10 to 13 mg/kg IV every 8 hours, maximum 900 mg per dose, can be used if susceptibility is reliable; otherwise use vancomycin with therapeutic drug monitoring.
• Drainage is required for most substantial purulent joint infections, by repeated aspiration, arthroscopic washout or open drainage depending on joint, disease severity and local expertise.
• Switch to appropriate oral therapy when fever resolves, joint function clearly improves and CRP is falling.
• Primary bacterial arthritis without adjacent osteomyelitis may require only 10 to 14 days total therapy when source control is adequate and clinical and CRP response is rapid. Slower response or inadequate drainage generally requires 21 to 28 days.